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Addition of glucose (5-20 mM) to rat adipocytes provoked ose-related increases in diacylglycerol, without increasing 
production of [aH]inositol phosphates. Cytosolic protein kinase C enzyme activity and immunoreactivity decreased within 
1-5 min of 5 mM glucose addition, and further over 20 min. Membrane protein kinase C increased stoichiometrically 
during the first 5 min and then decreased. Higher concentrations (10 and 20 mM) of glucose provoked greater and more 
rapid decreases of cytosolic and membrane protein kinase C. Our findings suggest hat glucose stimulates diacylglycerol 
production by providing substrate for phosphatidic acid synthesis de novo, and this is associated with translocative acti- 
vation of protein kinase C. 
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1. INTRODUCTION 
Protein kinase C (PKC) is a ubiquitous 
regulatory enzyme, which is activated by phospho- 
lipid, Ca 2+ and diacylglycerol (DAG) [1,2]. The 
DAG which derives from phospholipase C- 
mediated hydrolysis of phosphatidylinositol 
4',5'-bisphosphate (PIP2) [3] causes PKC to trans- 
locate from cytosol to the membrane, and this 
serves as evidence of PKC activation [4]. Some 
agonists, such as insulin, do not stimulate PIP2 
hydrolysis significantly, but increase DAG through 
enhanced synthesis of phosphatidic acid (PA) de 
novo [5-11], and hydrolysis of a phosphatidyl- 
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inositol (PI)-glycan [12] and phosphatidylcholine 
[11,13,14]. Insulin stimulates PKC translocation 
[15], but it is uncertain whether DAG derived from 
the de novo pathway contributes tothis activation. 
Recently, Draznin et al. [16] reported that in- 
sulin and glucose increase PKC-dependent histone 
phosphorylation and phorbol ester binding in 
crude cytosol of rat adipocytes. However, PKC 
translocation was not apparent, probably because 
PKC was not purified to remove activating factors, 
and binding assays may reflect release of the 
regulatory portion of PKC to the cytosol during ac- 
tivation. Using methodology described presently, 
we have observed typical PKC translocation re- 
sponses to insulin, phorbol esters and glucose in rat 
adipocytes. We report here that glucose stimulates 
DAG production through PA synthesis de novo, 
and that this is associated with PKC translocation. 
Abbreviations: PKC, protein kinase C; DAG, sn-l,2-diacyl- 
glycerol; IP, IP2 and IP3, inositol mono-, bis- and trisphos- 
phate; PA, phosphatidic acid; PI, phosphatidylinositol; PIP2, 
phosphatidylinositol 4,5-bisphosphate; PMSF, phenylmethyl- 
sulfonyl fluoride; SDS-PAGE, SDS-polyacrylamide g lelectro- 
phoresis 
2. EXPERIMENTAL 
Epididymal fat pads were obtained from fed male Holtzmann 
rats (200 g). Adipocytes were obtained by collagenase (Wor- 
thington, 1 mg/ml) digestion [17] of fat pads incubated for 
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30 rain at 37°C in Krebs-Ringer-Phosphate buffer (KRP) con- 
taining 307o BSA and 2.5 mM glucose. Adipocytes or fat pads 
were washed and equilibrated for 30 min in glucose-free KRP 
containing 1070 BSA, and then treated uring 20 or 30 rain in- 
cubation. (NB: similar conditions are commonly used in insulin 
studies, and insulin treatment for 30 min in glucose-free KRP 
provoked 2-4-fold increases in 2-[3H]deoxyglucose uptake.) 
To purify PKC, adipocytes or fat pads were washed 3 times 
and homogenized in ice-cold buffer I [20 m~d. Tris (pH 7.5), 
0.25 M sucrose, 1.2 mM EGTA, 0.1 mM I~MISF, 20/~g/ml 
leupeptin, 20 mM 2-mercaptoethanol] and ¢~ttrifuged at 
100000 × g for 60 min to obtain cytosol and min~brane frac- 
tions. The latter were suspended in buffer 1 containing 1070 
Triton X-100 and centrifuged to obtain solubilized membrane 
fractions. Cytosolic and solubilized membrane fractions (1 and 
0.3 mg protein, respectively) were applied to a Mono Q column 
(0.5 x 5 era, Pharmacia HR 5/5) connected to a Pharmacia fast 
protein liquid chromatography (FPLC) system equilibrated with 
buffer I1 [20 mM Tris (pH 7.5), 0.5 mM EGTA, 0.5 mM 
EDTA, 10 mM 2-mercaptoethanol] [18]. PKC was eluted (1-ml 
fractions) with a 20 ml linear gradient of NaCI (0-0.7 M) in buf- 
fer 1I. Two overlapping peaks of PKC enzyme activity were 
regularly observed. PKC enzyme activity was measured by phos- 
phorylation of type II[-S histone [19]. The reaction mixture 
(250~ul) contained 20 mM Tris (pH 7.5), 5 mM magnesium 
acetate, 0.0207o histone, 10/~M [7-32p]ATP (14 x 104 cpm/ 
nmol, ICN), 10/~g phosphatidylserine (PS), 0.1/zg diolein, 
0.5 mM CaC12, and 100/~1 of column fractions. After incuba- 
tion for 5 rain at 30°C, 25070 trichloroacetic a id was added, and 
precipitates were collected on nitrocellulose filters and counted 
for 32p. Basal activity was measured in the presence of 0.5 mM 
EGTA instead of Ca 2+, PS and diolein, and subtracted from the 
total activity to determine PKC activity . . . . . . .  
To measure immunoreactive PKC, 10/zg cytosol and 5/~g 
membrane protein were fractionated by SDS-PAGE [23], trans- 
ferred to nitrocellulose membranes [24], and blotted [15], using 
a polyclonal antiserum (supplied by J. Mehegan and B. Roth, 
Naval Medical Research Institute, Bethesda, MD) raised to syn- 
thetic peptide, specific to type II PKC, which is the only type 
that we find in adipose tissue after hydroxyapatite chromatog- 
raphy. 
DAG production was assessed by incubating 0.5 ml adipo- 
cytes with I/zCi [6-3H]glucose (ICN) and various concentrations 
of glucose. Lipids were extracted and DAG was purified by thin- 
layer chromatography [6,8,11], and counted for radioactivity. 
DAG content of lipid extracts was measured by the DAG kinase 
method (Lipidex) of Preiss et al. [20]. 
[3H]Inositol phosphate production was measured by in- 
cubating adipocytes for 1 h in glucose-free KRP with 10/zCi 
[3H]inositol (ARC). LiCI (5 mM) and, after 5 min, varying 
amounts of glucose were added. After 20 rain incubation, reac- 
tions were stopped with 507o tricbloroacetic acid. Acid-soluble 
fractions were extracted with ether, neutralized, and 
chromatographed on Dowex-I columns to purify inositol phos- 
phates (see [8,21,22]). Incorporation of [3H]inositol into phos- 
pholipids was measured by extracting trichloroacetic acid 
precipitate with CHCI~. 
3. RESULTS 
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Fig. 1. Time-course of effects of 5 mM glucose on PKC activity 
of cytosol ([;}--~]) and membrane (z z) fractions of rat 
adipocytes. Equal amounts of cytosolic or membrane protein 
from each group were applied to the Mono Q column. Total 
elutable PKC activity was calculated by summing the activities 
of all fractions, and found to be 80-150 and 70-120 pmol/min 
per mg protein, in control, cytosol and membrane fractions, 
respectively. Results are expressed as °7o of control PKC activity. 
Mean _+ SE of 2-,1 determinations from 5 separate xperiments. 
• P<0.025; ** P<0.01 (paired t-test of 4 comparisons). 
creased progress ively  dur ing a 20 min  incubat ion  
with 5 mM glucose ( f ig . l ) .  Membrane  PKC en- 
zyme act iv i ty increased dur ing  the first 5 min  o f  
g lucose t reatment ,  but  subsequent ly  decreased over  
the next  15 min.  T ime-dependent  changes in cyto-  
sol ic and membrane  immunoreact ive  PKC were 
also observed with 5 mM glucose t reatment  (f ig.2): 
cytosol ic  PKC decreased progress ively ,  whereas 
membrane  PKC increased dur ing the first 1-5 min  
(there was some var ia t ion  in the t iming o f  the peak) 
and then decreased.  
In  response to 5, 10, and 20 mM glucosel  de- 
creases in cytosol ic  PKC enzyme act iv i ty  were ap-  
parent  at 5 rnin, and greater  af ter  20 min  o f  in- 
cubat ion  (fig.3). Membrane  PKC increased dur ing 
a 5 min  incubat ion  with 5 mM glucose,  but  h igher  
concent ra t ions  o f  g lucose (10 and 20 raM) caused 
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Fig.2. Immunoblot analysis of 5 mM glucose-induced changes 
in immunoreactive PKC in cytosol and membrane fractions of 
rat adipocytes. 
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Fig.3. Glucose concentration-dependent activation of PKC in 
rat adipocytes (left) and fat pads (right). Adipocytes were in- 
cubated with 0, 5, I0, and 20 mM glucose for 5 or 20 min. Fat 
pads were incubated with 0, 5, 10, and 20 mM glucose for 
10 min. Total elutable PKC activity from Mono Q columns was 
calculated as in fig. 1. 
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PKC activity to decrease within the first 5 min. 
After 20 min incubation with 5, 10 and 20 mM 
glucose, membrane PKC activity was decreased 
in all cases. Glucose concentration-dependent 
changes in PKC enzyme activity were also 
demonstrated in fat pads. Cytosolic PKC de- 
creased progressively, and membrane PKC de- 
creased to a plateau during 10 min incubation with 
5, 10 and 20 mM glucose, respectively. 
Adipocyte DAG production from glucose 
(calculated from medium glucose specific activity) 
and the measured mass of DAG increased in 
parallel as functions of time and medium glucose 
concentration (fig.4). For example, after 20 min 
incubation with 0.1 and 20 mM glucose, DAG 
derived from [3H]glucose was 49 and 2207 pmol/ 
sample, respectively, and DAG content was 2275 
and 4470 (difference = 2195) pmol/sample. Glu- 
cose had no effect on production of [~H]-inositol 
phosphates, but did provoke small (15-50°70) in- 
creases in [3H]inositol labeling of adipocyte 
phospholipids, presumably reflecting increased 
synthesis (not shown). 
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Fig.4. Glucose-induced iacylglycerol (DAG) production in rat 
adipocytes. (A) Cells were incubated for 20 min with [3H]- 
glucose in KRP containing 0.1, 5, 10, and 20 mM glucose. (B) 
Cells were incubated with [3H]glucose in KRP containing 0.1 
(n ,  n) or 5 mM glucose (o, e) for 1, 5, 10, 20, and 30 min. 
Open and closed symbols indicate the calculated amounts of 
[3H]glucose converted to DAG, and DAG mass, respectively. 
Mean values from 5 experiments. SE values were less than 10%. 
4. DISCUSSION 
In this study, we found that glucose provoked 
rapid increases in DAG production in rat adipo- 
cytes, and that this was associated with apparent 
activation of PKC. The increases in DAG were 
derived solely or largely from de novo synthesis of 
PA. The activation of PKC was demonstrated by 
typical translocation, i.e. redistribution of PKC 
from cytosol to the membrane fraction, as ob- 
served in experiments in which 5 mM glucose was 
present for 5 min. This translocation pattern was 
apparent in studies of both PKC enzymatic activity 
following partial purification by FPLC on Mono Q 
columns, and immunoreactive PKC. In addition, 
this translocation pattern was only transiently 
observed, and was followed by decreases in mem- 
brane PKC, presumably reflecting time-dependent 
proteolytic conversion of PKC to the CaZ+/phos - 
pholipid-independent M-form of the enzyme 
[26,27]. At higher glucose concentrations, de- 
creases in cytosolic PKC were readily apparent, but 
initial increases in membrane PKC were not 
observed at 5 min; this suggests that with stronger 
activation of DAG-PKC signalling, there is more 
rapid activation of proteolytic enzymes which con- 
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vert PKC to M-kinase and possibly other related 
kinases. Along these lines, we observed increases in 
Ca2+/phospholipid-independent histone phospho- 
rylating activity during glucose treatment, but fur- 
ther studies will be required to determine whether 
this is M-kinase. 
Our results differ from those of Draznin et al. 
[16], who found that l0 mM glucose provoked in- 
creases in crude cytossolic PKC enzyme activity. 
However, we have found that considerable 
amounts of lipids (including DAG) are recovered in 
crude cytosol (probably artifactually), as well as 
membrane preparations, and this may increase the 
enzymatic activity of PKC, especially after glucose- 
stimulated DAG production. In our assays, we 
used PKC partially purified by chromatography on 
Mono Q columns, and this largely removes DAG, 
and possibly other endogenous activators. Thus, 
our assays, which contained optimal amounts of 
added diolein, would reflect changes in PKC con- 
tent more than activity. In keeping with this con- 
clusion is the fact that changes in immunoreactive 
PKC were similar to changes in histone phos- 
phorylating activity of the partially purified en- 
zyme. 
The finding of glucose-stimulated DAG produc- 
tion in [3H]glucose-labeled adipocytes i similar to 
that observed in pancreatic slets [28]. However, al- 
though glucose-stimulated DAG is largely derived 
from de novo PA synthesis [28], hydrolysis of PIP2 
and PI, and Ca 2+ mobilization are also stimulated 
by glucose in islets [29-31]. In adipocytes we did 
not obtain evidence of inositol phospholipid 
hydrolysis, and Draznin et al. [16] did not observe 
changes in cytosolic Ca 2+. Thus, it appeared that 
glucose-dependent i creases in adipocyte DAG 
were derived largely, if not solely, from PA syn- 
thesis de novo, and that this DAG was responsible 
for activation of PKC. Accordingly, DAG derived 
from the de novo pathway may also contribute to 
insulin- or other hormone-induced activation of 
PKC. 
It is surprising that a physiological concentration 
of glucose generates sufficient DAG by the de novo 
pathway, which, at least in the rat adipocyte, 
results in the activation of PKC. However, activa- 
tion of PKC by this mechanism is only partial, and, 
addition of insulin to adipocytes incubated in 5, l0 
and 20 mM glucose results in further PKC activa- 
tion (unpublished). Thus, in physiological condi- 
tions (i.e. et 5 mM glucose), de novo PA synthesis 
may provide a modest tonic stimulation of rat 
adipocyte PKC, which may be further activated by 
agents which stimulate DAG production through 
PA synthesis de novo and/or phospholipid hydro- 
lysis. 
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